Indications
Pyrukynd is indicated for the treatment of pyruvate kinase deficiency (PK deficiency) in adult patients (see section 4.4).
Composition
- Active substance
- mitapivat sulfate
- International name (INN)
- mitapivat
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Pyrukynd
- Active substance
- mitapivat sulfate
- ATC code
- B06AX04
- Therapeutic area
- Genetic Diseases, Inborn, Anemia, Hemolytic
- Marketing authorisation holder
- Agios Netherlands B.V.
- Status
- Authorised